Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.10
Bid: 40.72
Ask: 40.80
Change: -0.24 (-0.58%)
Spread: 0.08 (0.196%)
Open: 41.36
High: 41.40
Low: 40.40
Prev. Close: 41.34
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Nov 2020 11:54

RNS Number : 8554E
Assura PLC
10 November 2020
 

10 November 2020

Assura plc

("the Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

The Company announces that on 5 November 2020 the following named PDMRs acquired partnership shares and were awarded matching share awards over ordinary shares of 10 pence each in the Company under the Company's Share Incentive Plan ("SIP").

PDMR

Position

Number of partnership shares acquired

Number of matching shares awarded

Shareholding of PDMR and PCAs post acquisition and award

Jonathan Murphy

CEO

195

227

2,425,644

Jayne Cottam

CFO

195

227

175,096

Orla Ball

Company Secretary

195

227

1,468

 

The Notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

 

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jonathan Murphy

2

Reason for the notification

 

a)

Position/status

 

CEO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.7774 GBP

 

422

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.7774 GBP

 

 

422

 

£328.06 GBP

e)

Date of the transaction

 

5/11/2020

f)

Place of the transaction

 

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jayne Cottam

2

Reason for the notification

 

a)

Position/status

 

CFO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.7774 GBP

 

422

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.7774 GBP

 

 

422

 

£328.06 GBP

e)

Date of the transaction

 

5/11/2020

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Orla Ball

2

Reason for the notification

 

a)

Position/status

 

Company Secretary

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.7774 GBP

 

422

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.7774 GBP

 

 

422

 

£328.06 GBP

e)

Date of the transaction

 

5/11/2020

f)

Place of the transaction

 

XLON

 

 

 

For more information, please contact:

Assura plcOrla Ball, Company SecretaryDavid Purcell, Head of Investor Relations

Tel: 01925 420680Email: Investor@assura.co.uk

Finsbury

Gordon SimpsonJames Thompson

Tel: 0207 251 3801Email: Assura@Finsbury.com

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2020, Assura's property portfolio was valued at £2,139 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBBDBDUBDGGG
Date   Source Headline
23rd May 20133:30 pmRNSForm 8.3 - Assura Group Limited Replacement
23rd May 20133:05 pmRNSForm 8.3 - Assura Group Ltd
23rd May 20133:02 pmRNSForm 8.3 - Medicx Fund Ltd
23rd May 201311:07 amRNSForm 8.5 (EPT/NON-RI)
23rd May 20139:10 amRNSForm 8.5 (EPT/NON-RI)
23rd May 20138:53 amRNSForm 8.5 (EPT/NON-RI)
23rd May 20138:22 amRNSForm 8.5 (EPT/RI)
22nd May 20133:49 pmRNSForm 8.5 (EPT/NON-RI)- Replacement
22nd May 201312:41 pmRNSForm 8.3 - Assura Group
22nd May 201312:01 pmPRNForm 8.3 - Assura Group Ltd
22nd May 201311:37 amRNSForm 8.5 (EPT/RI)
22nd May 201310:25 amRNSForm 8.5 (EPT/RI)
22nd May 20139:50 amRNSForm 8.3 - Assura Group Limited
22nd May 20139:30 amRNSForm 8.5 (EPT/NON-RI)
22nd May 20138:49 amRNSForm 8.5 (EPT/NON-RI)
22nd May 20137:00 amBUSForm 8.3 - Assura Group Limited
21st May 20132:42 pmRNSForm 8.3 - Assura Group Limited
21st May 20139:42 amRNSForm 8.5 (EPT/NON-RI)
21st May 20139:16 amRNSForm 8.5 (EPT/RI)
21st May 20138:56 amRNSForm 8.5 (EPT/NON-RI)
20th May 20133:16 pmRNSForm 8.3 - MedicX Fund Limited
20th May 20132:57 pmRNSForm 8.3 - [Assura Group Limited]
20th May 20132:31 pmRNSForm 8.3 - Assura Group Ltd
20th May 201312:56 pmRNSForm 8.3 - MedicX Fund Limited
20th May 201312:17 pmBUSForm 8.3 - Assura Group Limited
20th May 201311:52 amRNSForm 8.5 (EPT/NON-RI)
20th May 201311:38 amRNSForm 8.5 (EPT/NON-RI)
20th May 201311:13 amRNSForm 8.5 (EPT/RI)
20th May 201310:54 amRNSForm 8.3 - Assura Group
20th May 20137:00 amRNSPossible offer update and Rule 2.10 disclosure
17th May 20136:24 pmRNSStatement re Possible Offer
17th May 20133:54 pmRNSAnnouncement re unsolicited approach
2nd Apr 20137:00 amRNSConfirmation of REIT status
13th Mar 201311:25 amRNSDirector/PDMR Shareholding
15th Feb 20133:20 pmRNSResults of EGM
31st Jan 20137:00 amRNSInterim Management Statement
29th Jan 20134:51 pmRNSNotification of Grant of Share Award to PDMR
28th Jan 20134:49 pmRNSNotice of Extraordinary General Meeting
8th Jan 20137:00 amRNSSale of Former Head Office Building
21st Dec 201211:38 amRNSConfirmation of Quarterly Interim Dividend
10th Dec 20122:58 pmRNSDirector/PDMR Shareholding
29th Nov 20126:33 pmRNSDirector Shareholding Announcement-Replacement
29th Nov 20124:33 pmRNSTransfer of Shares
28th Nov 20127:00 amRNSAssura Group Limited Interim Results 2012
13th Nov 201212:02 pmRNSAnnouncement of half year results date
28th Sep 20122:45 pmRNSConfirmation of Quarterly Interim Dividend
27th Sep 20129:00 amRNSAppointment of joint corporate broker
25th Sep 201210:00 amRNSAssura Group Transfer of Shares
21st Sep 20122:57 pmRNSHolding in Company - Laxey Partners Limited
18th Sep 20127:00 amRNSAppointment of Finance Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.